Equal Maintenance of Anti-SARS-CoV-2 Antibody Levels Induced by Heterologous and Homologous Regimens of the BNT162b2, ChAdOx1, CoronaVac and Ad26.COV2.S Vaccines: A Longitudinal Study Up to the 4th Dose of Booster

Several technological approaches have been used to develop vaccines against COVID-19, including those based on inactivated viruses, viral vectors, and mRNA. This study aimed to monitor the maintenance of anti-SARS-CoV-2 antibodies in individuals from Brazil according to the primary vaccination regim...

Full description

Saved in:

Bibliographic Details
Published in:	Vaccines (Basel) Vol. 12; no. 7; p. 792
Main Authors:	do Nascimento, Tatiana A, Nogami, Patricia Y, de Oliveira, Camille F, Neto, Walter F F, da Silva, Carla P, Ribeiro, Ana Claudia S, de Sousa, Alana W, Freitas, Maria N O, Chiang, Jannifer O, Silva, Franko A, das Chagas, Liliane L, Carvalho, Valéria L, Azevedo, Raimunda S S, Vasconcelos, Pedro F C, Costa, Igor B, Costa, Iran B, Barbagelata, Luana S, das Chagas Junior, Wanderley D, da Penha Junior, Edvaldo T, Soares, Luana S, Viana, Giselle M R, Amarilla, Alberto A, Modhiran, Naphak, Watterson, Daniel, Casseb, Lívia M N, Martins, Lívia C, Henriques, Daniele F
Format:	Journal Article
Language:	English
Published:	Switzerland MDPI AG 01-07-2024
Subjects:	Adenoviruses anti-RBD antibodies Antibodies ChAdOx1-S COVID-19 COVID-19 vaccines Disease transmission Enzymes Health aspects Infections Longitudinal studies Maintenance Measurement mRNA Neutralizing neutralizing antibodies Proteins Severe acute respiratory syndrome coronavirus 2 study longitudinal vaccine effectiveness Vaccines Viral antibodies Viral diseases Viral infections Brazil United States > US COVID-19 vaccine effectiveness BNT162b2 anti-RBD antibodies neutralizing antibodies ChAdOx1-S CoronaVac dose booster study longitudinal
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!